1[1]Araujo RW, Paiva V, Gartner F, et al. Fine needle aspiration as a tool to establish primary human breast cancer cultures in vitro. Acta Cytol, 1999,43(6) :985～90
2[2]Calaf GM, Hei TK. Establishment of a radiation-and estrogen-induced breast cancer model. Carcinogenesis, 2000,21 (4): 769～76
3[3]Wazer DE, Band V. Molecular and anatomic considerations in the pathogenesis of breast cancer. Radiat Oncol Investig. 1999,7(1): 1～12
4[4]Miller FR, Soule HD, Tait L, et al. Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst, 1993,85(21):1725～32
5[5]Kinzler KW,Vogelstein B.Gatekeepers and caretakers. Nature, 1997,386(6627) :761
6[6]Tomlinson GE, Chen TT, Stastny VA, et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.Cancer Res, 1998,58(15) :3237～42
7[7]Bems EMJJ, Klijn JGM , Putfen WLJ, et al. c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res, 1992,52(2); 1107
8[8]Tan M, Yao J, Yu D. Overexpression of the c-erbB-2gene enhanced intrinsic metastasis potential humam breast cancer cell without increasing their transformation abilities. Cancer Res, 1997,57 (6): 1199
9[9]Watanabe M, Tanaka H, Kamada M, et al. Establishment of the human RSMZ breast cancer cell line, which overexpresses erbB-2 and c-myc genes. the Cancer Res, 1992,52(19) :5178～82
10[10]Kurebavashi J, Otsuki T,Tang CK, et al.Isolation and characterization of a new human breast cancer cell line KPI-4, expressing the ErbB family receptors and interleukin 6 Bird Canaer,1999 ,79(5-6):707～17
